ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2025

A dose escalation and safety study of AAVrh10-mediated Schwann cell-targeted gene therapy for CMT1X.

Melina Christou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.